Delta-Fly Pharma, Inc.
Biopharmaceutical firm developing novel anticancer drugs from existing components.
4598 | T
Overview
Corporate Details
- ISIN(s):
- JP3549370009
- LEI:
- Country:
- Japan
- Address:
- 徳島市川内町宮島錦野３７番地の５
Description
Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer drugs. The company's core strategy is its proprietary "Module Drug Development" concept, an approach that combines existing pharmaceutical components to create novel therapeutic agents. This methodology aims to develop effective cancer treatments with significantly reduced side effects and at reasonable prices, thereby improving the quality of life for patients. The company's pipeline includes several drug candidates for various cancers, with some, such as DFP-10917 for refractory/relapsed acute myeloid leukemia, advancing to late-stage clinical trials. Delta-Fly Pharma focuses on creating gentle yet potent therapies, including nucleoside analogs and RNA therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-14 07:32 |
四半期報告書－第13期第3四半期(2022/10/01－2022/12/31)
|
Japanese | 208.2 KB | ||
| 2022-11-17 07:00 |
有価証券届出書（組込方式）
|
Japanese | 348.9 KB | ||
| 2022-11-14 07:27 |
確認書
|
Japanese | 9.0 KB | ||
| 2022-11-14 07:24 |
四半期報告書－第13期第2四半期(令和4年7月1日－令和4年9月30日)
|
Japanese | 164.8 KB | ||
| 2022-08-12 08:08 |
確認書
|
Japanese | 9.0 KB | ||
| 2022-08-12 08:08 |
四半期報告書－第13期第1四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | 134.3 KB | ||
| 2022-06-30 06:33 |
内部統制報告書－第12期(令和3年4月1日－令和4年3月31日)
|
Japanese | 22.7 KB | ||
| 2022-06-30 06:28 |
確認書
|
Japanese | 8.9 KB | ||
| 2022-06-30 06:25 |
有価証券報告書－第12期(令和3年4月1日－令和4年3月31日)
|
Japanese | 920.8 KB | ||
| 2022-02-14 08:28 |
四半期報告書－第12期第3四半期(令和3年10月1日－令和3年12月31日)
|
Japanese | 123.9 KB | ||
| 2021-11-11 07:09 |
四半期報告書－第12期第2四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | 147.5 KB | ||
| 2021-08-13 08:06 |
四半期報告書－第12期第1四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | 122.3 KB | ||
| 2021-07-06 04:09 |
確認書
|
Japanese | 8.1 KB | ||
| 2021-07-06 04:07 |
訂正有価証券報告書－第11期(令和2年4月1日－令和3年3月31日)
|
Japanese | 520.3 KB | ||
| 2021-06-30 07:15 |
確認書
|
Japanese | 8.1 KB |
Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Delta-Fly Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
